Selenoproteins (GPX4, SELENOP, SELENOK, SELENOT, GPX1, SELENOM, SELENOS, and SELENOW), which are highly expressed in the brain, specifically expressed in AD pathological regions, and closely associated with brain function, may be the most promising targets in AD research. This evidence concerns the gene GPX1 and Alzheimer disease.